Report #2878367

Received Dec 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 17 yrs
State: IA
Recovered: Recovered
Vaccinated: May 7, 2025
Onset: May 7, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	UNK	945665	—

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

Patient received HEPLISAV-B at age 17; Initial report received on 12-Nov-2025. A medical assistant reported that a 17-year-old female received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or concomitant medications were reported. On 07-May-2025, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot number 945665, expiration date 31-Jan-2027, and NDC number 43528-003-05; site not provided)] intramuscularly. The patient was 17 years old at the time of immunization. No side effects were reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.